Luo, Q., Whalen, K., Wu, X., Fortune, A., Zhang, L., Qian, W., Raulston, E., Nan, Y., Booth, C., Yan, K., Root, D., Doench, J., Lane, A. (2025). Khsrp depletion selectively eliminates AML cells that persist after venetoclax/azacitidine therapy via modulating SLC23A1-transported TET enzyme cofactors. Blood. https://doi.org/10.1182/blood-2025-638